Orphinic Scientific

Orphinic Scientific S.A. was funded in 2019 as the first Polish biotech portfolio platform creating innovative solutions for orphan diseases and other indications with significant unmet medical needs in the clinical trial phase. Orphinic core scientific team consist of experts with over 20 years experience in clinical development processes and their commercialization. The companys competencies in clinical stage development are further enforced through a collaboration with a large clinical CRO operating in the CEE region. This facilitates access to diverse patient populations and rapid enrollment to clinical trials supporting our projects and significantly shortens the duration of individual phases. Orphinic currently has 8 projects in the pipeline that range from a preclinical phase to market approval stages in three healthcare segments: therapeutics, medtech and e-health. We shorten time to the market due to specialized healthcare centers in CEE and an affiliated CRO. Our team...